| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |